Developing new treatments for respiratory infections using nanoformulations
Nanoformulations for Respiratory Infections
['FUNDING_OTHER'] · JAMES A. HALEY VA MEDICAL CENTER · NIH-10923474
This study is working on a new nasal treatment to help fight respiratory viruses like COVID-19 and RSV, especially for older adults who are more vulnerable, by using tiny particles to deliver medicine directly to the lungs and boost the immune system.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JAMES A. HALEY VA MEDICAL CENTER (nih funded) |
| Locations | 1 site (TAMPA, UNITED STATES) |
| Trial ID | NIH-10923474 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative antiviral treatments for respiratory infections, particularly targeting viruses like SARS-CoV-2 and RSV. The approach involves developing a specialized intranasal nanoformulation that utilizes liposomes to deliver therapeutic agents directly to the respiratory system. By incorporating specific compounds that can enhance the immune response and inhibit viral replication, the research aims to provide a more effective treatment option for patients, especially the elderly who are at higher risk. The methodology includes the use of advanced nanotechnology to ensure sustained release of the therapeutic agents.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly individuals aged 65 and older who are at risk for severe respiratory infections.
Not a fit: Patients under the age of 65 or those without a history of severe respiratory infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for severe respiratory infections, potentially reducing hospitalizations and improving survival rates among vulnerable populations.
How similar studies have performed: Previous research has shown promise in using nanotechnology for drug delivery in respiratory infections, indicating potential for success in this novel approach.
Where this research is happening
TAMPA, UNITED STATES
- JAMES A. HALEY VA MEDICAL CENTER — TAMPA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOHAPATRA, SHYAM S — JAMES A. HALEY VA MEDICAL CENTER
- Study coordinator: MOHAPATRA, SHYAM S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.